5.96
Finanzdaten der Edesa Biotech Inc-Aktie (EDSA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Research and Development |
8.23%
1.1247
|
1.2255 | 0.9391 | 0.4843 | 1.0198 |
| Operating Income/Loss |
5.22%
-2.3414
|
-2.4702 | -1.9037 | -1.6389 | -1.8987 |
| Nonoperating Income/Loss |
61.26%
0.0937
|
0.2419 | 0.1543 | 0.0492 | 0.2814 |
| Income/Loss From Continuing Operations Before Tax |
0.87%
-2.2477
|
-2.2284 | -1.7495 | -1.5896 | -1.6173 |
| Income/Loss From Continuing Operations After Tax |
0.87%
-2.2477
|
-2.2284 | -1.7495 | -1.5904 | -1.6173 |
|
|
0.87%
-2.2477
|
-2.2284 | -1.7495 | -1.5904 | -1.6173 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1,636%
7.9725
|
0.4594 | 7.0227 | 5.3058 | -0.9911 |
| Basic Earnings Per Share |
12.50%
-0.28
|
-0.32 | -0.25 | -0.30 | -0.44 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):